Founded in Golden, United States, Pharmajet, Inc. is a commercial medtech company focused on revolutionizing the delivery of medications and vaccines through needle-free injection systems. Their core mission is to enhance patient comfort and safety while improving the efficiency of vaccine and medication administration. Pharmajet's innovative intradermal injection devices eliminate the need for traditional needles and syringes, catering to a global market with a strong emphasis on healthcare accessibility and infection control.
Pharmajet has attracted notable investors and affiliations within the medical technology sector, contributing to its credibility and growth. The company has achieved significant milestones, including regulatory approvals and partnerships with global health organizations. These accomplishments underscore Pharmajet's impact on improving vaccination rates and reducing needle-stick injuries worldwide, positioning it as a key player in the medtech industry.
